Path Less Traveled: Targeting Rare Driver Oncogenes in Non-Small-Cell Lung Cancer
{{output}}
Over the past decade, tremendous efforts have been made in the development of targeted agents in non-small-cell lung cancer (NSCLC) with nonsquamous histology. Pivotal studies have used next-generation sequencing to select the patient population harboring onco... ...
